JAGSNPHARM
JAGSONPAL PHARMACEUTICALSHealthcare
LTP
231.21
CHG · %
-6.84 (-2.87%)
VOL · TODAY
70.63K
PREV CLOSE
238.05
Today's range229 · 239.68
231.21
52-week range155 · 282.7
231.21
Loading candles…
Jagsonpal Pharmaceuticals Ltd, incorporated in 1978, operates in the pharmaceutical industry with a focus on manufacturing and trading pharmaceutical products and active pharmaceutical ingredients. The company primarily serves the Indian market and concentrates on women's health and pain management through a niche-focused approach. Over time, Jagsonpal has established leadership in specific therapeutic molecules and expanded its portfolio via organic product launches and strategic acquisitions. Initially a family-run business, it transitioned to professional management after Infinity Holdings acquired a significant stake in June 2022.
JAGSNPHARM is not part of any active scan today.
This page is a live market overview for JAGSONPAL PHARMACEUTICALS (JAGSNPHARM) on the NSE. As a listed security, JAGSONPAL PHARMACEUTICALS is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for JAGSNPHARM before placing trades on tick2trade.
As of the latest feed, JAGSNPHARM last traded at ₹231.21 on NSE, down ₹6.84 (2.87%) from the previous close of ₹238.05. Today's session range is ₹229 – ₹239.68, against a 52-week band of ₹155 – ₹282.7. Traded volume today stands at 70.63K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for JAGSNPHARM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether JAGSNPHARM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for JAGSONPAL PHARMACEUTICALS before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in JAGSNPHARM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated JAGSNPHARM option chain page linked from this overview.
// similar in healthcare314 total